Official Publications Novartis AG

Equities

NOVN

CH0012005267

Real-time Estimate Cboe Europe Other stock markets 03:30:11 15/05/2024 pm IST			5-day change	1st Jan Change
93.44 ^CHF	-0.05%		+3.20%	+10.10%

13/05	Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales	DJ
10/05	Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation	MT

Official Publications

1st-half-year results	19/22/19	CO
1st-half-year results	19/22/19	CO
1st-half-year results	19/22/19	CO
Half-year report	19/22/19	CO
Slide show Q1	26/22/26	CO
1st quarter results	26/22/26	CO
1st quarter results	26/22/26	CO
1st quarter results	26/22/26	CO
1st quarter report	26/22/26	CO

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Novartis: 2024 has started on a strong note; guidance upgraded

NOVARTIS : 2024 has started on a strong note; guidance upgraded

April 23, 2024 at 10:54 pm IST

Vas Narasimhan, CEO of Novartis: 40% margin by 2027

April 23, 2024 at 04:48 pm IST

Vas Narasimhan, CEO of Novartis: 40% margin by 2027

Novartis AG : Sandoz takes its first steps on the stock exchange

October 04, 2023 at 08:02 pm IST

Novartis AG : Sandoz takes its first steps on the stock exchange

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW